Rice Hall James & Associates LLC raised its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 7.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 185,780 shares of the health services provider's stock after purchasing an additional 13,234 shares during the period. Rice Hall James & Associates LLC owned about 0.33% of Maximus worth $12,668,000 at the end of the most recent quarter.
Other institutional investors also recently bought and sold shares of the company. UMB Bank n.a. lifted its position in shares of Maximus by 70.2% in the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock valued at $41,000 after acquiring an additional 250 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Maximus by 67.1% in the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock valued at $50,000 after acquiring an additional 294 shares in the last quarter. Farther Finance Advisors LLC lifted its position in shares of Maximus by 109.2% in the fourth quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider's stock valued at $61,000 after acquiring an additional 428 shares in the last quarter. NBC Securities Inc. lifted its position in shares of Maximus by 114,900.0% in the first quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock valued at $78,000 after acquiring an additional 1,149 shares in the last quarter. Finally, Blue Trust Inc. lifted its position in shares of Maximus by 32.8% in the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock valued at $84,000 after acquiring an additional 303 shares in the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, Director Gayathri Rajan sold 7,913 shares of Maximus stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the transaction, the director owned 14,205 shares in the company, valued at approximately $1,028,157.90. This trade represents a 35.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 1.60% of the company's stock.
Analyst Ratings Changes
Separately, Wall Street Zen downgraded Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.
Check Out Our Latest Research Report on MMS
Maximus Price Performance
Shares of NYSE MMS traded up $0.29 during midday trading on Thursday, hitting $71.40. The stock had a trading volume of 317,873 shares, compared to its average volume of 573,551. The company has a market capitalization of $4.02 billion, a PE ratio of 14.19 and a beta of 0.61. The stock has a 50 day simple moving average of $71.83 and a 200-day simple moving average of $70.88. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.87.
Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. Maximus had a return on equity of 23.37% and a net margin of 5.56%. The firm had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter last year, the business posted $1.57 earnings per share. The firm's revenue was up 1.0% compared to the same quarter last year. On average, sell-side analysts expect that Maximus, Inc. will post 6.15 EPS for the current fiscal year.
Maximus Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.68%. Maximus's payout ratio is 23.86%.
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
